Skip to main content
logo
Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.7994
-0.0586 (-6.83%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7903
-0.0091 (-1.14%)
After-hours: Sep 18, 2026, 7:31 PM EDT

Clearmind Medicine Cash Flow Statement

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
-7.5-3.86-5.25-8.62-6.89-3
Depreciation & Amortization
0.050.050.050.060.080.01
Loss (Gain) From Sale of Investments
-1.94-0.840.070.110.31-
Stock-Based Compensation
1.790.8110.831.210.68
Other Operating Activities
0.86-0.85-0.592.290.33-
Change in Accounts Receivable
-0.110.020.06-0.150.02-0.13
Change in Accounts Payable
00.08-0.2-0.620.910.28
Change in Other Net Operating Assets
-0.24-0.140-0.190.3-0.13
Operating Cash Flow
-7.07-4.73-4.86-6.3-3.72-2.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Capital Expenditures
-----0.01-0.03
Sale (Purchase) of Intangibles
------0.16
Investment in Securities
-1.5-0.53-0.27---
Other Investing Activities
--0.010.03-0.03--0.02
Investing Cash Flow
-1.95-0.54-0.24-0.03-0.01-0.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Long-Term Debt Issued
-2.25----
Long-Term Debt Repaid
--0.04-0.04-0.04-0.07-
Lease Payments
-0.05-0.04-0.04-0.04-0.07-
Net Debt Issued (Repaid)
10.082.21-0.04-0.04-0.07-
Issuance of Common Stock
7.490.426.311.710.585.93
Financing Cash Flow
17.572.626.2511.660.515.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Foreign Exchange Rate Adjustments
-0.010-0.01-0.04-0.02-
Net Cash Flow
8.54-2.651.155.3-3.243.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Free Cash Flow
-7.07-4.73-4.86-6.3-3.73-2.31
Free Cash Flow Growth
------
Free Cash Flow Per Share
-13.96-372.53----
Levered Free Cash Flow
-4.78-3.82-3.13-0.15-0.88-1.33
Unlevered Free Cash Flow
-4.78-3.81-3.11-0.14-0.87-1.33
Free Cash Flow After Leases
-7.12-4.78-4.9-6.34-3.8-2.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash Interest Paid
000.0100.01-
Cash Income Tax Paid
0.080.230.310.01--
Change in Working Capital
-0.34-0.04-0.13-0.971.240.02
SEC Filings: 10-K · 10-Q